Turning Point Brands (TPB) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 Annual Meeting will be held virtually on May 8, 2025, with stockholders able to participate and vote online.
Key proposals include electing ten directors, amending the Certificate of Incorporation to limit officer liability, ratifying KPMG LLP as auditor, and an advisory vote on executive compensation.
The Board recommends voting in favor of all proposals and emphasizes increased board diversity and responsiveness to stockholder feedback.
Voting matters and shareholder proposals
Stockholders will vote on electing ten directors for one-year terms, an amendment to limit officer liability, ratification of KPMG LLP as auditor, and a non-binding say-on-pay vote.
The Board recommends voting “FOR” all proposals.
Stockholder proposals for the 2026 meeting must be submitted by November 24, 2025, to be included in proxy materials.
Board of directors and corporate governance
The Board expanded from nine to ten members, adding Kathleen Shanahan, with a focus on increasing diversity and expertise.
A majority of directors and nominees self-identify as women or people of color.
The Board has three standing committees: Audit, Compensation, and Nominating and Governance, all composed of independent directors.
Board leadership includes an Executive Chairman, CEO, and Lead Independent Director to ensure independent oversight.
Directors receive annual cash retainers and RSUs; committee chairs and the Lead Independent Director receive additional compensation.
Latest events from Turning Point Brands
- Modern Oral net sales jumped 133%, driving Q1 growth and higher FY 2026 guidance.TPB
Q1 20268 May 2026 - All board nominees, auditor ratification, and executive compensation were approved.TPB
AGM 20264 May 2026 - Modern Oral net sales jumped 266% in Q4, fueling 29% revenue growth and a strong 2026 outlook.TPB
Q4 20251 May 2026 - Annual meeting to vote on directors, auditor, and executive pay, with emphasis on diversity and governance.TPB
Proxy filing25 Mar 2026 - Q2 sales and EBITDA rose, guidance increased, and net income jumped 31% on strong segment growth.TPB
Q2 20242 Feb 2026 - Q3 2024 saw double-digit profit growth, raised guidance, and expanded share buybacks.TPB
Q3 202415 Jan 2026 - FY2024 net sales up 11% and EBITDA up 12%, with strong modern oral and core brand growth.TPB
Q4 202416 Dec 2025 - Key votes include director elections, auditor change, officer liability limits, and executive pay approval.TPB
Proxy Filing1 Dec 2025 - 2025 annual meeting moved to May 6 and will be held online; proposal deadlines updated.TPB
Proxy Filing1 Dec 2025